Singer Lee Chan-won continues ongoing donation activities with fans. On the 8th, the Korea Pediatric Cancer Foundation announced that Lee Chan-won donated the 1 million won prize money won at the December King of Singers competition to emergency treatment expenses for children suffering from pediatric cancer, leukemia, and rare incurable diseases. This donation was made possible by fans' support and was conducted through the donation platform SeonhanStar.

SeonhanStar is a donation platform that supports the positive influence of stars, where users participate in the King of Singers competition by watching videos and completing missions, and their support translates into donations based on rankings. Lee Chan-won's donation was made through the participation and encouragement of fans, giving it even deeper meaning. So far, Lee Chan-won has recorded a cumulative donation amount of 74.01 million won through SeonhanStar.

The donated funds will be used for emergency treatment expenses for children with pediatric cancer, leukemia, and rare incurable diseases. This donation aims to reduce treatment gaps by supporting hospitalization fees, medication costs, and auxiliary treatment expenses for families struggling with sudden high medical bills. Hong Seung-yoon, director of the Korea Pediatric Cancer Foundation, said, "We deeply appreciate the continuous sharing for the children," and added, "We sincerely support singer Lee Chan-won's future activities."

Lee Chan-won recently successfully completed the 'Changa: Brilliant Day' performances in Seoul and Daegu. Following this, the nationwide tour will continue in Incheon from January 10 to 11, in Busan from January 31 to February 1, and in Jinju from February 21 to 22. Lee Chan-won maintains ongoing communication with fans through these meetings.

Lee Chan-won's donation activities are not a one-time event but continuous sharing, strengthening the bond with fans. Lee Chan-won is expected to continue having a positive impact on society through various activities in the future.